<qa>  What is the feasibility of administering vincristine sulfate liposomeI. To determine the feasibility of administering vincristine sulfate liposome injection VSLI to relapsed or refractory acute myeloid leukemia AML patients having failed, refused or not a candidate for at least one chemotherapy salvage regimen. 